BCTX Briacell Therapeutics Corp

USD 2.17 -0.07 -3.125
Icon

Briacell Therapeutics Corp (BCTX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 2.17

-0.07 (-3.13)%

USD 0.04B

0.04M

USD 18.00(+729.49%)

USD 10.33 (+376.04%)

Icon

BCTX

Briacell Therapeutics Corp (USD)
COMMON STOCK | NSD
USD 2.17
0.00 0
Take a Tour

Briacell Therapeutics Corp (BCTX) Stock Forecast

Show ratings and price targets of :
USD 18.00
(+729.49%)

Based on the Briacell Therapeutics Corp stock forecast from 1 analysts, the average analyst target price for Briacell Therapeutics Corp is USD 18.00 over the next 12 months. Briacell Therapeutics Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Briacell Therapeutics Corp is Very Bearish, which is based on 0 positive signals and 6 negative signals. At the last closing, Briacell Therapeutics Corp’s stock price was USD 2.17. Briacell Therapeutics Corp’s stock price has changed by +7.43% over the past week, -14.57% over the past month and -69.48% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...